Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,948 public trials 736 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)

NCT01089127

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigator Site Florence, Alabama, United States
  • Novartis Investigator Site Jasper, Alabama, United States
  • Novartis Investigator Site Phoenix, Arizona, United States
  • Novartis Investigator Site Searcy, Arkansas, United States
View all 69 locations
View Trial Details
Completed

12-week Efficacy of Indacaterol

NCT01072448

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigator Site Peoria, Arizona, United States
  • Novartis Investigator Site Pine Bluff, Arkansas, United States
  • Novartis Investigator Site Buena Park, California, United States
  • Novartis Investigator Site Encinitas, California, United States
View all 62 locations
View Trial Details
Completed

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

NCT00900731

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigator Site Jasper, Alabama, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
View all 212 locations
View Trial Details
Completed

Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

NCT01068600

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Jasper, Alabama, United States
  • Novartis Investigator Site Glendale, Arizona, United States
  • Novartis Investigator Site Phoenix, Arizona, United States
View all 54 locations
View Trial Details
Completed

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00624286

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Jasper, Alabama, United States
  • Novartis Investigative Site Mobile, Alabama, United States
View all 120 locations
View Trial Details
Completed

Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control

NCT00393458

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigator Site Buenos Aires, Argentina
  • Novartis Buenos Aires, Argentina
  • Novartis Investigator Site Mendoza, Argentina
  • Novartis Investigator Site San Miguel, Argentina
View all 183 locations
View Trial Details
Completed

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

NCT00846586

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigator Site Birmingham, Alabama, United States
  • Novartis Investigator Site Mobile, Alabama, United States
  • Novartis Investigative Site Scottsdale, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
View all 137 locations
View Trial Details

Related conditions